Retained Earnings (Accumulated Deficit) of BIO-PATH HOLDINGS, INC. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
BIO-PATH HOLDINGS, INC. quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • BIO-PATH HOLDINGS, INC. Retained Earnings (Accumulated Deficit) for the quarter ending 30 Sep 2025 was $125,926,000, a 9.7% decline year-over-year.
Source SEC data
View on sec.gov
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

BIO-PATH HOLDINGS, INC. Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $125,926,000 -$11,178,000 -9.7% 30 Sep 2025 10-Q 13 Jan 2026 2025 Q3
Q2 2025 $124,950,000 -$12,317,000 -11% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $120,353,000 -$9,589,000 -8.7% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $117,501,000 -$9,894,000 -9.2% 31 Dec 2024 10-Q 13 Jan 2026 2025 Q3
Q3 2024 $114,748,000 -$10,513,000 -10% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $112,633,000 -$11,597,000 -11% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $110,764,000 -$13,962,000 -14% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $107,607,000 -$16,078,000 -18% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $104,235,000 -$16,672,000 -19% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $101,036,000 -$17,008,000 -20% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $96,802,000 -$15,782,000 -19% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $91,529,000 -$13,868,000 -18% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 $87,563,000 -$14,018,000 -19% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $84,028,000 -$12,552,000 -18% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $81,020,000 -$11,352,000 -16% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $77,661,000 -$10,440,000 -16% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $73,545,000 -$8,874,000 -14% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $71,476,000 -$9,773,000 -16% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $69,668,000 -$10,005,000 -17% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $67,221,000 -$10,882,000 -19% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 $64,671,000 -$10,721,000 -20% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $61,703,000 -$9,995,000 -19% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 $59,663,000 -$10,411,000 -21% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 $56,339,000 -$8,599,000 -18% 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q3 2019 $53,950,000 -$8,119,000 -18% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $51,708,000 -$8,958,000 -21% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $49,252,000 -$8,179,000 -20% 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 $47,740,000 -$8,583,000 -22% 31 Dec 2018 10-K 05 Mar 2020 2019 FY
Q3 2018 $45,831,000 -$8,841,000 -24% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 $42,750,000 -$8,234,000 -24% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 $41,073,000 -$8,542,000 -26% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 $39,157,000 -$7,023,000 -22% 31 Dec 2017 10-K 19 Mar 2019 2018 FY
Q3 2017 $36,990,000 -$6,227,000 -20% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 $34,516,000 -$5,323,000 -18% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $32,531,000 -$5,280,000 -19% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 $32,134,000 -$6,750,000 -27% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q3 2016 $30,763,000 -$6,837,978 -29% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 $29,193,000 -$6,775,579 -30% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 $27,251,000 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 $25,384,000 -$5,466,755 -27% 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q3 2015 $23,925,022 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 $22,417,421 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q4 2014 $19,917,245 31 Dec 2014 10-K 15 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.